Cargando…
Additional factors to corelate with a more than 30% NIHSS score improvement in patients 7 days after fibrinolytic and/or endovascular treatment for ischemic stroke
BACKGROUND: Our objective was to find which additional factors can influence the favorable result in stroke patients after receiving fibrinolytic and/or endovascular treatment, quantified as a more than 30% improvement of the NIHSS score at 7 days. METHODS: This is a retrospective study to find fact...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666450/ https://www.ncbi.nlm.nih.gov/pubmed/33189130 http://dx.doi.org/10.1186/s12883-020-01990-z |
_version_ | 1783610129315266560 |
---|---|
author | Tudor, Raluca Iovanescu, Gheorghe Reisz, Daniela Cornea, Amalia Potre-Oncu, Cristina Tutelca, Adrian Simu, Mihaela |
author_facet | Tudor, Raluca Iovanescu, Gheorghe Reisz, Daniela Cornea, Amalia Potre-Oncu, Cristina Tutelca, Adrian Simu, Mihaela |
author_sort | Tudor, Raluca |
collection | PubMed |
description | BACKGROUND: Our objective was to find which additional factors can influence the favorable result in stroke patients after receiving fibrinolytic and/or endovascular treatment, quantified as a more than 30% improvement of the NIHSS score at 7 days. METHODS: This is a retrospective study to find factors that could influence a favorable evolution of patients with stroke that underwent fibrinolytic and or thrombectomy using the NIHSS score changes. At the admission in the hospital, blood glucose, blood count, coagulation time, INR, aPTT, PT, platelet count, NIHSS questionnaire and ASPECTS score were collected. NIHSS was assessed at the admission, after 1 h, after 2 h, after 24 h and after 7 days. RESULTS: As compared to the initial evaluation, at 7 days after admission 59% (72) of patients have improved with more than 30% the NIHSS. Higher levels of systolic blood pressure, glycemia and lower ASPECTS score at admission were observed in non-achievers. The value of INR contributed to model: for every unit increase of INR, the chance of better outcome decreases by 90,1%. High glycemia has also a negative impact: for every unit increase, the chance of better outcome decreases by 24%. Higher initial ASPECTS score is associated with better outcomes: each point increase of ASPECTS score at initial evaluation, increases the chance of better outcome by 154.2%. CONCLUSION: Males, older age, diabetes, and hyperglycemia correlate with a worse outcome after cerebral stroke regardless of the benefit yielded fibrinolytic and/or thrombectomy therapy. In this study, patients with the above-mentioned factors did not improve more than 30% of baseline NIHSS score from admission to the 7th day. |
format | Online Article Text |
id | pubmed-7666450 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-76664502020-11-16 Additional factors to corelate with a more than 30% NIHSS score improvement in patients 7 days after fibrinolytic and/or endovascular treatment for ischemic stroke Tudor, Raluca Iovanescu, Gheorghe Reisz, Daniela Cornea, Amalia Potre-Oncu, Cristina Tutelca, Adrian Simu, Mihaela BMC Neurol Research Article BACKGROUND: Our objective was to find which additional factors can influence the favorable result in stroke patients after receiving fibrinolytic and/or endovascular treatment, quantified as a more than 30% improvement of the NIHSS score at 7 days. METHODS: This is a retrospective study to find factors that could influence a favorable evolution of patients with stroke that underwent fibrinolytic and or thrombectomy using the NIHSS score changes. At the admission in the hospital, blood glucose, blood count, coagulation time, INR, aPTT, PT, platelet count, NIHSS questionnaire and ASPECTS score were collected. NIHSS was assessed at the admission, after 1 h, after 2 h, after 24 h and after 7 days. RESULTS: As compared to the initial evaluation, at 7 days after admission 59% (72) of patients have improved with more than 30% the NIHSS. Higher levels of systolic blood pressure, glycemia and lower ASPECTS score at admission were observed in non-achievers. The value of INR contributed to model: for every unit increase of INR, the chance of better outcome decreases by 90,1%. High glycemia has also a negative impact: for every unit increase, the chance of better outcome decreases by 24%. Higher initial ASPECTS score is associated with better outcomes: each point increase of ASPECTS score at initial evaluation, increases the chance of better outcome by 154.2%. CONCLUSION: Males, older age, diabetes, and hyperglycemia correlate with a worse outcome after cerebral stroke regardless of the benefit yielded fibrinolytic and/or thrombectomy therapy. In this study, patients with the above-mentioned factors did not improve more than 30% of baseline NIHSS score from admission to the 7th day. BioMed Central 2020-11-14 /pmc/articles/PMC7666450/ /pubmed/33189130 http://dx.doi.org/10.1186/s12883-020-01990-z Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Tudor, Raluca Iovanescu, Gheorghe Reisz, Daniela Cornea, Amalia Potre-Oncu, Cristina Tutelca, Adrian Simu, Mihaela Additional factors to corelate with a more than 30% NIHSS score improvement in patients 7 days after fibrinolytic and/or endovascular treatment for ischemic stroke |
title | Additional factors to corelate with a more than 30% NIHSS score improvement in patients 7 days after fibrinolytic and/or endovascular treatment for ischemic stroke |
title_full | Additional factors to corelate with a more than 30% NIHSS score improvement in patients 7 days after fibrinolytic and/or endovascular treatment for ischemic stroke |
title_fullStr | Additional factors to corelate with a more than 30% NIHSS score improvement in patients 7 days after fibrinolytic and/or endovascular treatment for ischemic stroke |
title_full_unstemmed | Additional factors to corelate with a more than 30% NIHSS score improvement in patients 7 days after fibrinolytic and/or endovascular treatment for ischemic stroke |
title_short | Additional factors to corelate with a more than 30% NIHSS score improvement in patients 7 days after fibrinolytic and/or endovascular treatment for ischemic stroke |
title_sort | additional factors to corelate with a more than 30% nihss score improvement in patients 7 days after fibrinolytic and/or endovascular treatment for ischemic stroke |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7666450/ https://www.ncbi.nlm.nih.gov/pubmed/33189130 http://dx.doi.org/10.1186/s12883-020-01990-z |
work_keys_str_mv | AT tudorraluca additionalfactorstocorelatewithamorethan30nihssscoreimprovementinpatients7daysafterfibrinolyticandorendovasculartreatmentforischemicstroke AT iovanescugheorghe additionalfactorstocorelatewithamorethan30nihssscoreimprovementinpatients7daysafterfibrinolyticandorendovasculartreatmentforischemicstroke AT reiszdaniela additionalfactorstocorelatewithamorethan30nihssscoreimprovementinpatients7daysafterfibrinolyticandorendovasculartreatmentforischemicstroke AT corneaamalia additionalfactorstocorelatewithamorethan30nihssscoreimprovementinpatients7daysafterfibrinolyticandorendovasculartreatmentforischemicstroke AT potreoncucristina additionalfactorstocorelatewithamorethan30nihssscoreimprovementinpatients7daysafterfibrinolyticandorendovasculartreatmentforischemicstroke AT tutelcaadrian additionalfactorstocorelatewithamorethan30nihssscoreimprovementinpatients7daysafterfibrinolyticandorendovasculartreatmentforischemicstroke AT simumihaela additionalfactorstocorelatewithamorethan30nihssscoreimprovementinpatients7daysafterfibrinolyticandorendovasculartreatmentforischemicstroke |